CoChat

Human autologous iPSC–derived dopaminergic progenitors restore motor function in Parkinson’s disease models

Open access
Song, Bin, Cha, Young, Ko, Sanghyeok, Jeon, Jeha, Lee, Nayeon, Seo, Hyemyung, Park, Kyung-Joon, Lee, In-Hee, Lopes, Claudia, Feitosa, Melissa, Luna, María José, Jung, Jin Hyuk, Kim, Jisun, Hwang, Dabin, Cohen, Bruce M., Teicher, Martin H., Leblanc, Pierre, Carter, Bob S., Kordower, Jeffrey H., Bolshakov, Vadim Y., Kong, Sek Won, Schweitzer, Jeffrey S., Kim, Kwang-Soo · 2020 · Journal of Clinical Investigation
Cited by 189

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder associated with loss of striatal dopamine, secondary to degeneration of midbrain dopamine (mDA) neurons in the substantia nigra, rendering cell transplantation a promising therapeutic strategy. To establish human induced pluripotent stem cell-based (hiPSC-based) autologous cell therapy, we report a platform of core techniques for the production of mDA progenitors as a safe and effective therapeutic product. First, by combining metabolism-regulating microRNAs with reprogramming factors, we developed a method to more efficiently generate clinical-grade iPSCs, as evidenced by genomic integrity and unbiased pluripotent potential. Second, we established a "spotting"-based in vitro differentiation methodology to generate functional and healthy mDA cells in a scalable manner. Third, we developed a chemical method that safely eliminates undifferentiated cells from the final product. Dopaminergic cells thus express high levels of characteristic mDA markers, produce and secrete dopamine, and exhibit electrophysiological features typical of mDA cells. Transplantation of these cells into rodent models of PD robustly restores motor function and reinnervates host brain, while showing no evidence of tumor formation or redistribution of the implanted cells. We propose that this platform is suitable for the successful implementation of human personalized autologous cell therapy for PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci130767

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 189

Metadata

Authors
Song, B., Cha, Y., Ko, S., Jeon, J., Lee, N., Seo, H., Park, K.-J., Lee, I.-H., Lopes, C., Feitosa, M., Luna, M. J., Jung, J. H., Kim, J., Hwang, D., Cohen, B. M., Teicher, M. H., Leblanc, P., Carter, B. S., Kordower, J. H., Bolshakov, V. Y., Kong, S. W., Schweitzer, J. S., & Kim, K.-S.
Venue
Journal of Clinical Investigation
Published
2020-01-13
Volume
130
Issue
2
Pages
904-920
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2988909735
Cited by
189
References
15
FWCI
5.23
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human autologous iPSC–derived dopaminergic progenitors restore motor function in Parkinson’s disease models. https://app.cochat.ai/papers/10.1172/jci130767
The paper
Song, B., Cha, Y., Ko, S., Jeon, J., Lee, N., Seo, H., Park, K.-J., Lee, I.-H., Lopes, C., Feitosa, M., Luna, M. J., Jung, J. H., Kim, J., Hwang, D., Cohen, B. M., Teicher, M. H., Leblanc, P., Carter, B. S., Kordower, J. H., . . . Kim, K.-S. (2020). Human autologous iPSC–derived dopaminergic progenitors restore motor function in Parkinson’s disease models. Journal of Clinical Investigation. https://doi.org/10.1172/jci130767

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.